← all combinations medical emergency

MDMA + SSRI / SNRI

We recommend avoiding this combination. No numeric safety recommendation possible.

review pending

Content is undergoing medical and legal review. Changes possible.

Substances involved

Risk profile

SSRIs/SNRIs partly block MDMA's effect at the serotonin transporter. Result: weaker subjective effect, stronger temptation to redose — at the same time an increased serotonin syndrome risk from growing accumulation.

Acute emergency scenarios

SSRIs/SNRIs (citalopram, sertraline, venlafaxine, fluoxetine, duloxetine, escitalopram, etc.) block the serotonin reuptake transporter. MDMA releases serotonin through exactly this transporter.

Consequences:

  • Dampened MDMA effect — some users barely notice anything
  • Temptation to redose — higher total dose, higher toxicity risk
  • Serotonin syndrome — documented at higher MDMA doses and longer SSRI use
  • Delayed complications — sleep problems, low mood, and panic days later

The washout period depends on the substance:

  • Sertraline, citalopram, escitalopram: about 1 week
  • Fluoxetine: 4–6 weeks because of the long half-life of active metabolites
  • Venlafaxine, duloxetine: 1–2 weeks
  • MAO inhibitors (moclobemide, tranylcypromine): see MDMA + MAOI (deep red)

We recommend avoiding MDMA use during SSRI/SNRI therapy. If you use anyway: only low doses, never redose, and with someone not on an SSRI/SNRI nearby.

Talking to a doctor before using substances makes sense especially with long-term antidepressant use — many doctors will advise you without judgment if you ask directly.